Market News & Trends
Mithra Agrees to Exclusive Long-Term Agreement With Mayne Pharma
Mithra Pharmaceuticals recently announced an exclusive long-term license and supply agreement that extends beyond 10 years with Mayne Pharma, a leading specialty pharmaceutical company, for…
Japanese Pharmaceutical Market to Rise to $72 billion by 2021
The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual…
Advaxis & SELLAS Announce Licensing Agreement for Antigen-Targeting Immunotherapy
Advaxis, Inc. and SELLAS Life Sciences Group recently announced that Advaxis has granted SELLAS a license to develop a novel cancer immunotherapy agent using Advaxis’…
International Stem Cell Corporation Announces Third Patient With Parkinson's Disease in Clinical Trial
International Stem Cell Corporation recently announced the third patient in the clinical trial for Parkinson's Disease was successfully transplanted with ISC-hpNSC cells and is already…
Checkpoint Therapeutics Announces Issuance of US Composition of Matter Patent for Lung Cancer Compound
Checkpoint Therapeutics, Inc. recently announced that the US Patent and Trademark Office has issued a composition of matter patent for CK-101 (also known as RX518),…
Essen BioScience to be Acquired for $320 Million
Essen BioScience Inc., a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research applications, recently signed…
nLife Therapeutics Enters Research Collaboration With WAVE Life Sciences
nLife Therapeutics S.L. recently announced the initiation of a research collaboration aimed at exploring cell-specific targeting of nucleic-acid therapeutics in the central nervous system (CNS)…
Gerresheimer AG Appoints New CEO
Dr. Christian Fischer will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive…
Essen BioScience to be Acquired for $320 Million
Essen BioScience Inc., a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research applications, recently signed…
nLife Therapeutics Enters Research Collaboration With WAVE Life Sciences
nLife Therapeutics S.L. recently announced the initiation of a research collaboration aimed at exploring cell-specific targeting of nucleic-acid therapeutics in the central nervous system (CNS)…
Gerresheimer AG Appoints New CEO
Dr. Christian Fischer will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive…
TruTag Technologies & Spinnaker Biosciences Enter Strategic Partnership for Controlled-Release Drug Delivery
TruTag Technologies recently announced it has entered into a strategic partnership with Spinnaker Biosciences for suppling Spinnaker with precision-fabricated nano-porous silica particles (pSi). Spinnaker Biosciences…
Neovacs & BioSense Sign Lucrative Option Agreement
Neovacs recently announced it has signed with BioSense Global LLC a commercial license option agreement for its IFNα Kinoid vaccine to treat lupus and dermatomyositis…
MilliporeSigma Offers Fully Integrated ADC Services to Reduce Complexity, Accelerate Time to Market
MilliporeSigma recently announced it now offers complete and fully integrated services and products for the development and manufacturing of antibody-drug conjugates (ADCs) from gene sequencing…
Mayne Pharma Launches Methylphenidate Extended-Release Capsules in the United States
Mayne Pharma Inc. recently announced the launch of methylphenidate extended-release capsules, 60 mg, in the United States. Methylphenidate is a generic alternative to Ritalin LA…
IDBS & ChemAxon Partnership Extends to Harness Leading Biomolecule Handling Technology
IDBS recently announced that the strategic technology partnership with ChemAxon has been further strengthened. IDBS is now able to leverage ChemAxon’s Biomolecule Toolkit and BioEddie…
Cellect Biotechnology Announces Positive Clinical Trial Results
Cellect Biotechnology Ltd. recently announced positive final results from its clinical trial of ApoGraft in healthy donors. The study’s primary objective was to validate the…
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with…
Science-Based Games & Books for Children Demystifies Intimidating Concepts
Genius Games is a publishing company that focuses science-based games, children's books, and toys. We have sold science-based products to over 50 countries globally, with…
Selecta Biosciences Announces Preclinical Data Showing Potential Benefit in Treatment of Pompe Disease
Selecta Biosciences, Inc. recently announced that results from preclinical studies involving the use of SVP-Rapamycin in combination with alglucosidase alfa (marketed as Myozyme and Lumizyme)…
